PMC:7253235 / 42175-42505 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1371","span":{"begin":37,"end":41},"obj":"Gene"},{"id":"1372","span":{"begin":43,"end":47},"obj":"Gene"},{"id":"1373","span":{"begin":48,"end":51},"obj":"Gene"},{"id":"1380","span":{"begin":156,"end":164},"obj":"Species"},{"id":"1409","span":{"begin":7,"end":13},"obj":"Disease"},{"id":"1410","span":{"begin":176,"end":190},"obj":"Disease"},{"id":"1411","span":{"begin":242,"end":256},"obj":"Disease"}],"attributes":[{"id":"A1371","pred":"tao:has_database_id","subj":"1371","obj":"Gene:2064"},{"id":"A1372","pred":"tao:has_database_id","subj":"1372","obj":"Gene:673"},{"id":"A1373","pred":"tao:has_database_id","subj":"1373","obj":"Gene:5609"},{"id":"A1380","pred":"tao:has_database_id","subj":"1380","obj":"Tax:9606"},{"id":"A1409","pred":"tao:has_database_id","subj":"1409","obj":"MESH:D009369"},{"id":"A1410","pred":"tao:has_database_id","subj":"1410","obj":"MESH:D066126"},{"id":"A1411","pred":"tao:has_database_id","subj":"1411","obj":"MESH:D066126"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"• Some cancer treatments (i.e., anti-HER2, BRAF-MEK treatments, clinical trials) require frequent surveillance of cardiac function (i.e., every 3 months)\n• Patients with known cardiotoxicity, or with known treatments that can cause long-term cardiotoxicity (i.e., anthracyclines, radiation) may not get timely surveillance imaging"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T423","span":{"begin":7,"end":13},"obj":"Disease"}],"attributes":[{"id":"A423","pred":"mondo_id","subj":"T423","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"• Some cancer treatments (i.e., anti-HER2, BRAF-MEK treatments, clinical trials) require frequent surveillance of cardiac function (i.e., every 3 months)\n• Patients with known cardiotoxicity, or with known treatments that can cause long-term cardiotoxicity (i.e., anthracyclines, radiation) may not get timely surveillance imaging"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T117","span":{"begin":48,"end":51},"obj":"Chemical"},{"id":"T118","span":{"begin":264,"end":278},"obj":"Chemical"}],"attributes":[{"id":"A117","pred":"chebi_id","subj":"T117","obj":"http://purl.obolibrary.org/obo/CHEBI_28398"},{"id":"A118","pred":"chebi_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/CHEBI_48120"},{"id":"A119","pred":"chebi_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/CHEBI_49322"}],"text":"• Some cancer treatments (i.e., anti-HER2, BRAF-MEK treatments, clinical trials) require frequent surveillance of cardiac function (i.e., every 3 months)\n• Patients with known cardiotoxicity, or with known treatments that can cause long-term cardiotoxicity (i.e., anthracyclines, radiation) may not get timely surveillance imaging"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T236","span":{"begin":7,"end":13},"obj":"Phenotype"}],"attributes":[{"id":"A236","pred":"hp_id","subj":"T236","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"• Some cancer treatments (i.e., anti-HER2, BRAF-MEK treatments, clinical trials) require frequent surveillance of cardiac function (i.e., every 3 months)\n• Patients with known cardiotoxicity, or with known treatments that can cause long-term cardiotoxicity (i.e., anthracyclines, radiation) may not get timely surveillance imaging"}